In addition, co-culture of activated B cells of SLE patients with sema3A reduced the expression of TLR-9 in these B cells, thus suggesting that sema3A is a modulator in reducing autoimmunity [21]. This evidence concerns the gene SEMA3A and systemic lupus erythematosus.